Neoadjuvant chemotherapy for high-risk upper tract urothelial cancer. [PDF]
Malshy K, Messing EM.
europepmc +1 more source
<p>[Corrigendum] Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells<br><br></p>. [PDF]
Zhong Y +8 more
europepmc +1 more source
Exosomal miR-20a-5p derived from cisplatin-resistant osteosarcoma cells promotes chemoresistance via Inhibition of ferroptosis through targeting RUNX3. [PDF]
Zhang P +5 more
europepmc +1 more source
Supplementation With Curcumin Exhibits Nephroprotective Effects in Cisplatin-Induced Acute Kidney Injury. [PDF]
Zhang M +5 more
europepmc +1 more source
Mechanistic Fingerprints from Chloride to Iodide: Halide vs. Ammonia Release in Platinum Anticancer Complexes. [PDF]
Chiaverini L +14 more
europepmc +1 more source
Correction to "Nanoliposomal Formulation of <i>Gynura procumbens</i> Leaf Extract Potentiates Hepatorenal Protection in Cisplatin-Induced Rats". [PDF]
europepmc +1 more source
Related searches:
Cisplatin is a widely used anti-cancer drug that is exceptionally effective against testicular cancer. trans-DDP, the geometric isomer of cisplatin, is ineffective as a chemotherapeutic agent. The anti-tumour activity of cisplatin is generally attributed to its formation of DNA adducts, both intrastrand and interstrand crosslinks, which induce ...
E E, Trimmer, J M, Essigmann
openaire +2 more sources
Cisplatin is used widely in the treatment of a large number of carcinomas. The clinical use of cisplatin, however, can be complicated by myelotoxicity, ototoxicity and intestinal toxicity; we review briefly cisplatin nephrotoxicity. The principal route of its excretion is via the kidney, and accumulation of cisplatin in the renal cortex has been ...
J P, Fillastre, G, Raguenez-Viotte
openaire +2 more sources

